Variant name,CP,VP,mAbs phase3,mAbs structure,other mAbs
B.1.1.7,475,611,67,33,228
B.1.351,423,418,61,21,142
B.1.351 RBD,169,66,26,10,113
P.1,106,144,25,5,47
S:69del+70del,77,22,20,17,70
B.1.429,46,115,9,3,39
S:614G,44,71,6,4,40
S:242del+243del+244del,42,42,16,11,43
S:444T+445S+446T,36,0,0,1,8
S:455Y+456L,36,0,0,1,8
S:470N+471V+472P,36,0,0,1,8
B.1.1.7 +S:484K,20,58,0,0,0
S:484K+501Y,19,54,5,2,18
S:69del+70del+501Y+681H,18,13,2,0,2
Mink Cluster 5,18,0,2,0,2
S:69del+70del+501Y,15,31,15,6,47
S:69del+70del+453F,15,11,4,4,13
PT188_EM,15,0,0,0,4
S:69del+70del+501Y+570D,10,15,0,0,0
COH.20G/677H,10,5,2,0,2
B.1.351 :-18F-244del-246I,7,39,0,1,3
B.1.351 :-18F-242del-243del-244del-246I,6,39,0,1,3
P.2,5,29,0,0,0
S:69del+70del+796H,3,0,0,3,9
S:477N+514F,2,0,0,0,10
S:345A+517R,2,0,0,0,10
SARS-CoV,1,63,0,0,0
S:446P+456V+484P,1,0,0,0,0
B.1.1.298,0,26,0,0,0
B.1.351 :-246I,0,24,4,0,9
B.1.351 :-18F-246I,0,24,0,0,0
WIV1,0,24,0,0,0
B.1.351 :-18F-215G,0,23,0,0,0
B.1.1.50 +S:681H,0,18,0,0,0
S:417N+501Y,0,10,0,0,0
S:417N+484K,0,10,0,0,0
B.1.526,0,0,3,0,5
S:69del+70del+439K,0,0,3,0,3
S:80A+215G+484K+501Y+701V,0,0,2,0,2
S:145del+408I,0,0,1,4,13
S:417T+484K+501Y,0,0,1,0,2
S:417T+484K,0,0,1,0,2
S:261D+453F,0,0,1,0,1
S:354K+95I,0,0,1,0,1
S:354D+364Y,0,0,1,0,1
B.1.1.7 S1,0,0,1,0,1
S:453F+498H,0,0,1,0,1
S:69del+70del+453F+486L+501T+1229I,0,0,1,0,1
S:439K+1121L,0,0,0,2,2
S:475V+261D,0,0,0,2,2
S:490L+779H,0,0,0,2,2
S:324G+325D,0,0,0,1,8
